David Moskowitz
David Moskowitz
add further pressure suicidal warning
A new warning (on suicidal thoughts) could further add to pressure on the product.
negative outcome positive trial
A negative outcome in this trial is more magnified than a positive one.
blatant decision protecting says
This is really bad. It is such a blatant decision that says Merck did not do the right thing about protecting patients.
cases company number squeeze stability types
The squeeze is coming, ... With this number of cases and these types of awards, the stability of the company is at risk.
beyond case cases patients relevant taken
What Merck has going for them in this case is that the plaintiffs are still alive. Beyond that, these are the more relevant cases to the plaintiffs because the patients allegedly have taken the drug for more than the 18-month interval. It makes the case more compelling.